Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Allograft Recipients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01055964
What this trial is testing

A Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients

Who this might be right for
PharmacokineticsTacrolimus
Seoul National University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04204980
What this trial is testing

Desensitization in Kidney Allograft Using Daratumumab

Who this might be right for
AllosensitizationKidney Transplant RejectionAntibody-mediated Rejection
Assistance Publique - Hôpitaux de Paris 21
Post-approval studies (Phase 4)Ended earlyNCT01371344
What this trial is testing

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 47
Not applicableStudy completedNCT02233491
What this trial is testing

Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients

Who this might be right for
Post Transplantation Diabetes MellitusObesityTransplantation of Kidney
University Hospital Birmingham NHS Foundation Trust 130
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Post-approval studies (Phase 4)WithdrawnNCT01269684
What this trial is testing

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00518271
What this trial is testing

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 120
Not applicableStudy completedNCT01289717
What this trial is testing

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Who this might be right for
Kidney TransplantKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 307
Post-approval studies (Phase 4)Study completedNCT00713284
What this trial is testing

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic

Who this might be right for
Renal Transplantation
California Pacific Medical Center Research Institute 29
Large-scale testing (Phase 3)Study completedNCT00195273
What this trial is testing

Study Evaluating Sirolimus in Kidney Transplant Recipients

Who this might be right for
Graft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 61
Testing effectiveness (Phase 2)Study completedNCT01666951
What this trial is testing

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 36
Testing effectiveness (Phase 2)Ended earlyNCT03591380
What this trial is testing

CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Wisconsin, Madison 3
Not applicableStudy completedNCT06476717
What this trial is testing

Donor-derived Cell-free DNA in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAcute Rejection of Renal Transplant
Institute for Clinical and Experimental Medicine 143
Testing effectiveness (Phase 2)Ended earlyNCT01517984
What this trial is testing

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

Who this might be right for
Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)UnknownNCT02057965
What this trial is testing

Mesenchymal Stromal Cell Therapy in Renal Recipients

Who this might be right for
Renal Transplant RejectionFibrosis
Leiden University Medical Center 70
Post-approval studies (Phase 4)Study completedNCT01469884
What this trial is testing

Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

Who this might be right for
Renal AllograftHepatitis C
Irmandade Santa Casa de Misericórdia de Porto Alegre 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907096
What this trial is testing

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Who this might be right for
Delayed Graft Function
argenx 103
Post-approval studies (Phase 4)UnknownNCT00443508
What this trial is testing

Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

Who this might be right for
Kidney Diseases
Rabin Medical Center 60
Post-approval studies (Phase 4)Study completedNCT00261820
What this trial is testing

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 160
Post-approval studies (Phase 4)Study completedNCT01601821
What this trial is testing

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Who this might be right for
Inflammation
Pfizer 245
Next Page